iPSC

Lucid Diligence Brief - BioPharma

United Therapeutics’ Thymmune acquisition | Lucid Diligence Brief

United Therapeutics adds Thymmune’s iPSC thymic-cell platform to its…

by Sreyashi Paul

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Aspen Neuroscience $115M Series C

Lucid Diligence Brief: Aspen Neuroscience $115M Series C Professional audiences…

by Timos Papagatsias

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - October 2nd 2025

Gene & Cell Therapy Update: eXmoor × Siam Bioscience Partnership, FDA Fast…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.